跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DABIGATRAN SANDOZ dabigatran etexilate (as mesilate) 75 mg capsule bottle - TGA Drug Approval Details
Approvals
/
TGA
/
DABIGATRAN SANDOZ dabigatran etexilate (as mesilate) 75 mg capsule bottle
Approved
STANDARD
DABIGATRAN SANDOZ dabigatran etexilate (as mesilate) 75 mg capsule bottle
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
aaca2dda19fae07e
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
aaca2dda19fae07e
Product Name
DABIGATRAN SANDOZ dabigatran etexilate (as mesilate) 75 mg capsule bottle
Artg Id
450486
Artg Name
DABIGATRAN SANDOZ dabigatran etexilate (as mesilate) 75 mg capsule bottle
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2024-08-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
aaca2dda19fae07e
Type
Standard
Back to TGA Approvals